Who owns Lineage Cell Therapeutics In?
- Ticker: LCTX
- CUSIP Number: 53566p109
Tip: Access positions for across all investors
Analyze quarterly positions in Lineage Cell Therapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lineage Cell Therapeutics In stock
Who bought or sold Lineage Cell Therapeutics In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 8.4M | $9.1M | 1% | Dec 2023 |
|
| Defender Capital | 5.0M | $5.4M | -4% | Dec 2023 |
|
| Raffles Associates | 2.1M | $2.3M | 34% | Dec 2023 |
|
| Prescott General Partners | 1.9M | $2.0M | 0% | Dec 2023 |
|
| MAI Wealth Advisors | 804k | $876k | -16% | Dec 2023 |
|
| Jpmorgan Chase & Co | 727k | $792k | 2% | Dec 2023 |
|
| Citadel Advisors | 592k | $645k | 43% | Dec 2023 |
|
| Laurion Capital Management | 434k | $473k | -62% | Dec 2023 |
|
| Charles Schwab Investment Management | 363k | $396k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 358k | $390k | 0% | Dec 2023 |
|
| Long Focus Capital Management | 215k | $234k | 0% | Dec 2023 |
|
| Barclays | 183k | $200k | 664% | Dec 2023 |
|
| Royal Bank of Canada | 174k | $185k | 948% | Dec 2023 |
|
| Squarepoint Ops | 173k | $189k | 604% | Dec 2023 |
|
| Jane Street | 164k | $179k | 290% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 163k | $177k | -11% | Dec 2023 |
|
| UBS Group | 145k | $163k | 173% | Dec 2023 |
|
| Rhumbline Advisers | 112k | $122k | 0% | Dec 2023 |
|
| T. Rowe Price Associates | 91k | $100k | 7% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 76k | $83k | -3% | Dec 2023 |
|
| MetLife Investment Advisors | 69k | $75k | 0% | Dec 2023 |
|
| American International | 66k | $72k | 2% | Dec 2023 |
|
| Wells Fargo & Company | 61k | $66k | 17% | Dec 2023 |
|
| Millennium Management | 58k | $63k | 100% | Dec 2023 |
|
| HighTower Advisors | 54k | $59k | 0% | Dec 2023 |
|
| Commonwealth Equity Services | 48k | $52k | -12% | Dec 2023 |
|
| Beirne Wealth Consulting Services | 45k | $49k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 40k | $44k | 0% | Dec 2023 |
|
| Two Sigma Advisers | 38k | $41k | -3% | Dec 2023 |
|
| Goldman Sachs Group | 37k | $41k | 25% | Dec 2023 |
|
| Florida State Board of Administration | 37k | $40k | 0% | Dec 2023 |
|
| Hrt Financial | 36k | $39k | 100% | Dec 2023 |
|
| Trust Co Of Toledo Na | 34k | $50k | 0% | Mar 2024 |
|
| SG Americas Securities | 31k | $34k | 62% | Dec 2023 |
|
| United Bank | 30k | $33k | 0% | Dec 2023 |
|
| Creative Planning | 26k | $29k | -7% | Dec 2023 |
|
| Bank of America Corporation | 24k | $26k | 272% | Dec 2023 |
|
| Citigroup | 24k | $26k | -82% | Dec 2023 |
|
| Victory Capital Management | 24k | $26k | 22% | Dec 2023 |
|
| PFG Investments | 21k | $31k | 5% | Mar 2024 |
|
| Raymond James & Associates | 20k | $30k | 0% | Mar 2024 |
|
| Fifth Third Wealth Advisors | 20k | $30k | 100% | Mar 2024 |
|
| Allegheny Financial Group | 20k | $22k | 0% | Dec 2023 |
|
| Alliancebernstein | 18k | $19k | 0% | Dec 2023 |
|
| Farrow Financial | 17k | $19k | 100% | Dec 2023 |
|
| Scotia Capital | 17k | $18k | 0% | Dec 2023 |
|
| Principal Financial Group | 16k | $18k | 7% | Dec 2023 |
|
| Straight Path Wealth Management | 16k | $18k | 0% | Dec 2023 |
|
| Legal & General Group | 16k | $17k | 0% | Dec 2023 |
|
| AE Wealth Management | 16k | $17k | 0% | Dec 2023 |
|
| Madrona Financial Services | 15k | $22k | 0% | Mar 2024 |
|
| Beacon Capital Management | 15k | $18k | 100% | Dec 2023 |
|
| SkyOak Wealt | 15k | $16k | 0% | Dec 2023 |
|
| Mariner Wealth Advisors | 15k | $16k | -54% | Dec 2023 |
|
| Lafayette Investments | 13k | $14k | 0% | Dec 2023 |
|
| Two Sigma Securities | 13k | $14k | 100% | Dec 2023 |
|
| Piscataqua Savings Bank | 13k | $19k | 0% | Mar 2024 |
|
| ELCO Management | 12k | $13k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 11k | $12k | 0% | Dec 2023 |
|
| Summit Trail Advisors | 10k | $15k | 100% | Mar 2024 |
|
| Quadrant Private Wealth Management | 10k | $11k | 0% | Dec 2023 |
|
| Fisher Investments | 10k | $11k | 100% | Dec 2023 |
|
| Riggs Asset Managment | 9.6k | $11k | -9% | Dec 2023 |
|
| Simplex Trading | 9.6k | $10k | 618% | Dec 2023 |
|
| Lazard Asset Management | 9.4k | $0 | 7% | Dec 2023 |
|
| Founders Capital Management | 8.0k | $12k | 0% | Mar 2024 |
|
| Hanson McClain Advisors | 4.8k | $5.2k | 0% | Dec 2023 |
|
| Amalgamated Bank | 4.4k | $6.0k | -76% | Mar 2024 |
|
| New York State Common Retirement Fund | 3.2k | $3.0k | -11% | Dec 2023 |
|
| Albion Financial Group | 3.0k | $4.5k | 0% | Mar 2024 |
|
| Pacifica Partners | 2.9k | $3.7k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 2.2k | $2.3k | -95% | Dec 2023 |
|
| Lindbrook Capital | 1.8k | $1.9k | 0% | Dec 2023 |
|
| CWM | 1.5k | $2.0k | 100% | Mar 2024 |
|
| BFSG | 355.00 | $526.003500 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 300.00 | $327.000000 | 0% | Dec 2023 |
|
| Pnc Financial Services | 180.00 | $196.002000 | 100% | Dec 2023 |
|
| Planning Capital Management Corp | 100.00 | $109.000000 | 100% | Dec 2023 |
|
| Coppell Advisory Solutions | 63.00 | $68.997600 | -61% | Dec 2023 |
|
| Central Trust & Investment | 29.00 | $31.998600 | 0% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 14.00 | $14.999600 | 0% | Dec 2023 |
|
| Focused Wealth Management | 8.00 | $9.000000 | 0% | Dec 2023 |
|
| Newbridge Financial Services Group | 5.00 | $5.000000 | 0% | Dec 2023 |
|
| D. J. St. Germain | 2.00 | $2.000000 | 0% | Dec 2023 |
|
| Plante Moran Financial Advisors | 2.00 | $2.000000 | 100% | Dec 2023 |
|
Who sold out of Lineage Cell Therapeutics In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| D. E. Shaw & Co | Sep 2023 | 51k | $60k |
| Summit X | Sep 2023 | 11k | $13k |
| USAdvisors Wealth Management | Sep 2023 | 11k | $12k |
| Metropolitan Life Insurance Company | Sep 2023 | 7.1k | $8.4k |